Dr. David Allen Vandemerwe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir, Farmington, UT 84025 Phone: 801-773-4840 Fax: 801-525-8151 |
Daniel H Chappell, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 991 Shepard Ln, Suite 200, Farmington, UT 84025 Phone: 801-397-6080 Fax: 801-397-6081 |
Ziyi Wang, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 444 W Bourne Cir Ste 101, Farmington, UT 84025 Phone: 801-294-9333 Fax: 801-294-7558 |
Mr. Hans C Jenkins, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 722 Shepard Ln, Suite 102, Farmington, UT 84025 Phone: 385-988-3965 Fax: 385-988-3972 |
Spencer David Cline, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir, Farmington, UT 84025 Phone: 801-773-4840 Fax: 801-525-8151 |
Julie C Hibbard, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 N 1075 W, Suite 220, Farmington, UT 84025 Phone: 801-451-4538 Fax: 801-451-2295 |
Daniel Wilford Broadbent, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 991 Shepard Ln, Ste 200, Farmington, UT 84025 Phone: 801-397-6080 Fax: 801-397-6081 |
Sally S Tan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 N Highway 89, Suite 220, Farmington, UT 84025 Phone: 801-451-4538 Fax: 801-451-2295 |
News Archive
GenoMed, Inc. has announced that the leading experts in West Nile virus encephalitis in Belarus will collaborate with the Company in treating cases of suspected West Nile virus encephalitis this summer. Belarus, formerly part of the USSR, is now a democratic country of 10.5 million people lying between Poland and Russia; its capital is Minsk.
The force gravity and physical activity put on our bones causes tiny tears in the membranes of the tiny cells that enable us to make or break down bone, scientists say.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.
Although clots in the lung (pulmonary embolism or PE) are the second-leading cause of sudden death in the United States, blood tests and ultrafast CT scanning to detect PE are being used on so many patients that over 90% of these tests are negative.
› Verified 3 days ago